Skip to content

Application of partial intestine rotation in pancreatoduodenectomy: a prospective, randomized, controlled, single-center study

Application of partial intestine rotation in pancreatoduodenectomy: a prospective, randomized, controlled, single-center study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035913
Enrollment
Unknown
Registered
2020-08-20
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreaticoduodenectomy

Interventions

Partial intestine rotation:Partial intestine rotation
Conventional operation group:Conventional operation group

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) signed Informed consent; (2) Aged 18 to 80 years; (3) Preoperative imaging examination suggested periampullary carcinoma, pancreatic head carcinoma or other malignant lesions indicated by pancreaticoduodenectomy.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart and lung diseases who cannot tolerate pancreaticoduodenectomy or have other contraindications for pancreaticoduodenectomy; (2) Preoperative hemoglobin < 70g/L or albumin < 30g/L; (3) Those who have had organ transplant operation in the past and take immunosuppressive drugs; (4) those taking hormones, immunosuppressants or chemotherapy; (5) Persons with known HIV infection; (6) Suspicion of non-compliance or non-cooperation; (7) Crohn's disease; (8) The investigator believes that the subject has a mental disability or other defect that may prevent him from participating in the study; (9) Intraoperative exploration revealed that the tumor could not be resected or complicated with acute pancreatitis. (10) Intraoperative exploration revealed extensive adhesion in the surgical area, and partial intestinal dissociation rotation could not be completed.

Design outcomes

Primary

MeasureTime frame
Number of lymph node dissection;

Secondary

MeasureTime frame
operating time;intraoperatve blood soss;blood transfusion volume;Postoperative drainage volume;

Countries

China

Contacts

Public ContactWu Wenchuan

Zhongshan Hospital Fudan University

Wu.wenchuan@zs-hospital.sh.cn+86 13916104911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026